Tag: Bempegaldesleukin

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Bempegaldesleukin

Nektar Therapeutics (NASDAQ:NKTR) CAO Jillian B. Thomsen Sells 2713 Shares

Added to Collection on: 2019-12-15 13:26:15

Tags for this article:

Financial markets
Finance
Nektar Therapeutics
Financial economics
Bempegaldesleukin
Price?earnings ratio
Stock

Click the tags to see associated articles and topics

View Article Details
Nektar Therapeutics (NASDAQ:NKTR) Upgraded to Hold by BidaskClub

Added to Collection on: 2019-12-18 09:18:45

Tags for this article:

Financial markets
Stock market
Equity securities
Finance
Financial economics
Nektar Therapeutics
Stock
Price?earnings ratio
Share
Bempegaldesleukin

Click the tags to see associated articles and topics

View Article Details
Metropolitan Life Insurance Co NY Sells 5967 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Added to Collection on: 2020-01-03 13:33:58

Tags for this article:

Financial markets
Equity securities
Stock market
Finance
Financial economics
Nektar Therapeutics
Bempegaldesleukin
Price?earnings ratio
Stock
Nektar
Share
METROPOLITAN LIFE INSURANCE CO NY

Click the tags to see associated articles and topics

View Article Details
Private Asset Management Inc. Takes Position in Nektar Therapeutics (NASDAQ:NKTR)

Added to Collection on: 2020-01-03 19:31:25

Tags for this article:

Financial markets
Finance
Nektar Therapeutics
Financial economics
Bempegaldesleukin
Price?earnings ratio
Stock
Private Asset Management Inc

Click the tags to see associated articles and topics

View Article Details
In an end-of-year surprise, AstraZeneca nabs rare disease stalwart Alexion in $39B buyout. But why?

Added to Collection on: 2020-12-12 14:27:53

Tags for this article:

Medical specialties
Branches of biology
Clinical medicine
Immunology
Immune system
T cells
Interleukins
Lymphocytes
Cytotoxic T cell
Natural killer cell
CD8
Bempegaldesleukin

Click the tags to see associated articles and topics

View Article Details
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development

Added to Collection on: 2021-02-18 13:30:00

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Cancer immunotherapy
Antineoplastic drugs
Immunology
Interleukin 2
Interleukins
Bempegaldesleukin
Tumor microenvironment
Immunotherapy
Electroporation
Oncosec Medical Incorporated
Bridget O'Keeffe

Click the tags to see associated articles and topics

View Article Details
Nektar Therapeutics (NASDAQ:NKTR) Director Sells $151840.00 in Stock

Added to Collection on: 2021-04-17 23:37:30

Tags for this article:

Bempegaldesleukin
Nektar Therapeutics
Companies
Pharmacology
Health care

Click the tags to see associated articles and topics

View Article Details
Nektar Therapeutics (NASDAQ:NKTR) Director Robert Chess Sells 8000 Shares

Added to Collection on: 2021-05-15 23:03:07

Tags for this article:

Bempegaldesleukin
Nektar Therapeutics
Life Sciences
Health care
Biotechnology

Click the tags to see associated articles and topics

View Article Details
Global NK Cell Therapies Pipeline Market Report 2021 - ResearchAndMarkets.com

Added to Collection on: 2021-06-14 15:45:00

Tags for this article:

Branches of biology
Medical specialties
Clinical medicine
Immune system
Cancer treatments
Lymphocytes
Immunology
Natural killer cell
Oncology
NK-92
Bempegaldesleukin
Cancer immunotherapy

Click the tags to see associated articles and topics

View Article Details
NK Cell Therapy Pipeline, Clinical Trials Studies, Emerging Drugs, and FDA Approvals 2023 ...

Added to Collection on: 2023-10-09 21:14:56

Tags for this article:

Biotechnology
Bempegaldesleukin
NK-92
Natural killer cell
Cell therapy
Therapy
Regenerative Medicine Advanced Therapy
Sotio

Click the tags to see associated articles and topics

View Article Details